Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Inés Ibarra‐Lecue, Irene Mollinedo-Gajate, J. Javier Meana, Luis Felipe Callado, Rebeca Dı́ez-alarcia, Leyre Urigüen
Neuropsychopharmacology April 27, 2018 DOI: 10.1038/s41386-018-0076-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Mice exposed to chronic THC early in life |
| Intervention | rapamycin |
| Topics | Cannabis Serotonin |
| Citations | 78 |
| Key findings | Chronic early THC exposure in mice induced a pro-hallucinogenic 5-HT2AR conformation and supersensitive coupling to inhibitory G-proteins, accompanied by exacerbated schizophrenia-like responses such as prepulse inhibition disruption; rapamycin blocked these changes. The authors propose this as a mechanistic link between adolescent cannabis exposure and later psychosis-like behaviors. |
Abstract
Long-term use of potent cannabis during adolescence increases the risk of developing schizophrenia later in life, but to date, the mechanisms involved remain unknown. Several findings suggest that the functional selectivity of serotonin 2A receptor (5-HT2AR) through inhibitory G-proteins is involved in the molecular mechanisms responsible for psychotic symptoms. Moreover, this receptor is dysregulated in the frontal cortex of schizophrenia patients. In this context, studies involving cannabis exposure and 5-HT2AR are scarce. Here, we tested in mice the effect of an early chronic Δ 9 -tetrahydrocannabinol (THC) exposure on cortical 5-HT2AR expression, as well as on its in vivo and in vitro functionality. Long-term exposure to THC induced a pro-hallucinogenic molecular conformation of the 5-HT2AR and exacerbated schizophrenia-like responses, such as prepulse inhibition disruption. Supersensitive coupling of 5-HT2AR toward inhibitory Gαi1-, Gαi3-, Gαo-, and Gαz-proteins after chronic THC exposure was observed, without changes in the canonical Gαq/11-protein pathway. In addition, we found that inhibition of Akt/mTOR pathway by rapamycin blocks the changes in 5-HT2AR signaling pattern and the supersensitivity to schizophrenia-like effects induced by chronic THC. The present study provides the first evidence of a mechanistic explanation for the relationship between chronic cannabis exposure in early life and increased risk of developing psychosis-like behaviors in adulthood.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.
Citations in the library
Cited by 13
- Pivotal mental states Journal of Psychopharmacology April 1, 2021
- Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Proceedings of the National Academy of Sciences January 25, 2021
- Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology November 4, 2021
- New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity Cell Death Discovery May 1, 2024
- Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods. Journal of Cannabis Research July 11, 2024
and 8 more in the library
Cites 9
- Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Journal of Neuroscience October 1, 2003
- Effect of Hallucinogens on Unconditioned Behavior Current Topics in Behavioral Neurosciences 2016
- AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. Translational Psychiatry February 16, 2016
- Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. Neurotoxicology and Teratology 2016
- Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology June 2013
and 4 more in the library